Our in vitro studies indicate that ADAMTS19 downregulation reduces the motility of cancer cells (Fig. 6 and Additional file 1: Figure S7), suggesting that ADAMTS19 hypermethylated cells could be less capable to escape the tumor mass and migrate to distant organs through the vascular system. Here, ADAMTS19 is linked to cancer.